Navigation Links
Study provides new understanding of forces behind seasonal flu virus evolution
Date:4/16/2008

WHAT: Do influenza viruses persist in low levels year-round in the northern and southern hemispheres, or does a new crop of the virus emerge afresh in tropical zones such as Southeast Asia before spreading into temperate regions around the globe" Researchers have provided an answer to this long-standing question: new strains arise each year.

The new findings should help public health officials more quickly and accurately determine which strains to include in the annual flu vaccine.

The study, supported in part by the National Institutes of Health (NIH), appears online in advance of print in the journal Nature.

The researchers analyzed full gene sequences of seasonal influenza virus samples collected from the worlds temperate regions north and south of the equator. Their data comprised full genetic sequences of 1,302 isolates of influenza A virus collected over 12 years from New Zealand and New York state.

By quantifying the degree of genetic diversity among the strains subtypes, gene segments and geographic locations, the researchers were able to detect patterns indicating that virus strains do not persist from one flu season to the next in the temperate regions. Therefore, the researchers deduced, new flu strains emerge annually from the tropics.


'/>"/>

Contact: Anne A. Oplinger
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Page: 1

Related medicine news :

1. Seasonal Flu Outbreaks Start in Asia: Study
2. Study examines the effect of epilepsy on the aging
3. Study shows pine bark naturally reduces osteoarthritis
4. Study Shows Pine Bark Naturally Reduces Osteoarthritis
5. Study suggests too much screen time and not enough physical activity may lead to childhood obesity
6. St. Jude gene study reveals basis of anticancer drug resistance in childhood leukemia
7. UAB study shows investigational drug may treat biliary cancers
8. Study shows that high-dose, high-frequency interferon produces no additional benefit
9. Study finds media coverage of breast cancer focuses too little on prevention
10. USC study finds evidence of gender-related differences in development of colon cancer
11. New study in JCSM finds that obesity can predict upper airway obstruction amongst children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... Raton (PRWEB) , ... September 19, 2017 , ... ... the El Naturalista brand, developed by ACPG Laboratories, is coming soon to RonnieColemanNutrition.com. ... in Spain, and El Naturalista is a trusted, well-respected brand reliant on the ...
(Date:9/19/2017)... ... ... For decades doctors, nurses, and other healthcare providers have been trained to ... calculating their cardiovascular disease (CVD) risk in the next 10 years. , Imagine ... an estimated 10-year risk prediction! , Imagine if the weatherman says there is a ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... with the Davidson Fellows Scholarship on September 27 at a reception in Washington ... Technology, Engineering, Mathematics, Literature and Music. , “I am honored to be a ...
(Date:9/19/2017)... ... September 19, 2017 , ... Emergency nursing expertise, skill ... Emergency Nurse (CEN®) certification according to a large-scale study announced today by ... conducted by the Human Resources Research Organization (HumRRO) in late 2016 and early ...
(Date:9/18/2017)... Bangkok, Thailand (PRWEB) , ... September 19, 2017 ... ... in Asia Pacific’s protein ingredient market , expected to grow at the ... Frost & Sullivan sharing the ‘Global Food Protein Trends & Growth Opportunities in ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Sept. 7, 2017   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue hypothermic storage ... Mike Rice , President and CEO, will be presenting ... Rodman & Renshaw 19 th Annual Global Investment ... (12:25 p.m. Pacific time). The conference is being held at ...
(Date:9/6/2017)... INDIANAPOLIS , Sept. 6, 2017 Eli ... today it will present new data for galcanezumab and ... Congress of the International Headache Society (IHC) taking place ... Lilly will highlight new, long-term data from ... two doses of galcanezumab (120 mg and 240 mg) ...
(Date:9/5/2017)... JERUSALEM , Sept. 5, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has successfully concluded its meeting with the U.S. ... novel oral insulin formulation. ... that the regulatory pathway for submission of ORMD-0801, would ...
Breaking Medicine Technology: